quisqualic acid has been researched along with bay36-7620 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bischoff, F; Janssen, C; Langlois, X; Lavreysen, H; Lesage, AS; Leysen, JE | 1 |
| Azuma, T; Fukuda, J; Hata, M; Hikichi, H; Ito, S; Kaneko, N; Kawagoe-Takaki, H; Kawamoto, H; Kimura, T; Maehara, S; Ohta, H; Sakai, N; Satow, A; Suzuki, G | 1 |
| Beltramo, M; Brusa, R; Lozza, G; Mancini, I; Petrò, R; Reggiani, A; Scandroglio, P | 1 |
| Banda, M; DeVries, JA; Gorski, DH; Mekani, T; Smith, JS; Speyer, CL | 1 |
| Li, HY; Liao, YW; Liu, Q; Sang, SS; Su, J; Wang, XY; Yuan, XR; Zhang, C; Zhao, ZJ | 1 |
5 other study(ies) available for quisqualic acid and bay36-7620
| Article | Year |
|---|---|
[3H]R214127: a novel high-affinity radioligand for the mGlu1 receptor reveals a common binding site shared by multiple allosteric antagonists.
Topics: Adamantane; Allosteric Regulation; Animals; Binding Sites; Binding, Competitive; Brain; Cell Line; Cell Membrane; CHO Cells; Chromones; Cricetinae; Humans; Naphthalenes; Pyrans; Quinolines; Quinoxalines; Quisqualic Acid; Radioligand Assay; Rats; Receptors, Metabotropic Glutamate; Transfection; Tritium | 2003 |
Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC).
Topics: Animals; Benzimidazoles; Binding, Competitive; Calcium Signaling; Cell Line; Cell Membrane; CHO Cells; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Glutamic Acid; Humans; Inositol Phosphates; Male; Mice; Mice, Inbred ICR; Molecular Structure; Motor Activity; Naphthalenes; Point Mutation; Quisqualic Acid; Rats; Receptors, Metabotropic Glutamate; Thiazoles; Transfection; Triazoles | 2007 |
Evaluation of cannabinoid receptor 2 and metabotropic glutamate receptor 1 functional responses using a cell impedance-based technology.
Topics: Analgesics; Animals; Benzimidazoles; Biological Assay; Calcium; Cannabinoids; CHO Cells; Chromones; Cricetinae; Cricetulus; Cyclic AMP; Cyclohexanols; Cycloleucine; Electric Impedance; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Glycine; Indoles; Naphthalenes; Neuroprotective Agents; Quinolines; Quisqualic Acid; Receptor, Cannabinoid, CB2; Receptors, Metabotropic Glutamate; Resorcinols; Signal Transduction; Thiazoles | 2010 |
Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Female; Humans; Injections, Intraperitoneal; Mice; Mice, Nude; Naphthalenes; Phenotype; Quisqualic Acid; Receptors, Metabotropic Glutamate; Riluzole; RNA Interference; Signal Transduction; Time Factors; Transfection; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
Anti-cancer effect of metabotropic glutamate receptor 1 inhibition in human glioma U87 cells: involvement of PI3K/Akt/mTOR pathway.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Movement; Glioma; Humans; MAP Kinase Signaling System; Mice; Mice, Nude; Molecular Targeted Therapy; Naphthalenes; Quisqualic Acid; Receptors, Metabotropic Glutamate; Riluzole; RNA, Small Interfering; Xenograft Model Antitumor Assays | 2015 |